1 min left

0% read

Lantern Pharma

Infrastructure

Software

Technology Company

Dallas, Texas, USA

Founded 2013

Lantern Pharma, Inc.

Lantern Pharma, Inc. is a clinical stage pharmaceutical company developing new classes of precision cancer drugs with novel mechanisms of action, and also rescuing or revitalizing abandoned or failed cancer drugs using machine learning techniques, genomic data, and precision oncology trials.

Lantern Pharma recognizes that the high cost and low success rates in oncology drug development largely stem from the inability to appropriately stratify patient populations prior to enrollment, and also from the inability to fully elucidate mechanisms of action that can suggest potent combinations. Our approach, which leverages our RADR platform, helps to provide rapid, meaningful insight to both of these central problems in oncology.

Lantern is focused on accelerating personalized cancer therapy development through the use of AI and genomic-based patient stratification.

Frequently Asked Questions About Lantern Pharma

Lantern Pharma is a company in the cryptocurrency and blockchain space. Visit their profile on Crypto News Navigator for details about their services, team, and company background.

Lantern.

Lantern Pharma has been operating since 2013. You can verify their legitimacy through their official website and social media presence.

Lantern Pharma operates in the infrastructure sector of the cryptocurrency industry. Compare Lantern Pharma with other infrastructure companies on Crypto News Navigator to evaluate services, features, and reputation before making your decision.

Before using Lantern Pharma, research their track record (operating since 2013), verify their regulatory compliance, read user reviews, and understand their fee structure. Never share your private keys with any service, and start with small amounts until you are comfortable with the platform.

Safety depends on multiple factors including regulatory compliance, security practices, and track record. Lantern Pharma is based in Dallas, Texas, USA, has been operating since 2013. Always enable two-factor authentication, use strong passwords, and never store large amounts on any third-party platform.

Lantern Pharma is based in Dallas, Texas, USA, North America.

Lantern Pharma was founded in 2013. The company currently has 18 employees.

Lantern Pharma Details

Lantern Pharma Tags

More About Lantern Pharma

Work Model Details

Employees work from physical offices.

Latest from Academy

RUNE Wallets Ranked by Security, Speed, and Cross-Chain Features

RUNE is the native asset of THORChain, the cross-chain liquidity protocol whose vaults were exploited for more than $10 million in May 2026, hitting 12,847 wallets across Bitcoin, Ethereum, BNB Chain, and Base. The breach was a protocol-level failure no wallet could have prevented, but the wallet a holder used decided how fast they saw the pause warning and how exposed their funds were. Native wallets like Asgardex and THORWallet flagged the validator pause at the protocol level, while most multi-chain users only found out once Thorchain was trending online. This comparison grades the leading options for holding and swapping RUNE on security architecture, swap speed, and native cross-chain features. The takeaway is that for RUNE, your real risk exposure depends on wallet choice far more than on any rune price prediction.

Crypto News NavigatorMay 25, 2026

8m read

DeXe Built a DAO Platform That Actually Ships Products

DeXe (DEXE) is a no-code DAO governance protocol whose DAO Studio lets anyone deploy and run a decentralized organization using more than sixty modular, audited smart contracts. DEXE traded around $13.59 with a market cap above $1.1 billion, up roughly 386% from its February lows, while protocol TVL climbed to $1.7 billion across more than one hundred DAOs. DeXe has shipped working software where most DAO tooling projects stalled, with audits from Cyfrin, Hacken, CertiK, and Ambisafe and staking yields reported up to 102% APR. Yet the holder base has stayed near 50,000 even as capital concentrated, raising a concentration question the price has yet to resolve. Regulatory tailwinds from MiCA and proposed U.S. rules could favor auditable on-chain governance, but execution still needs user growth to back the valuation.

Archie DuttonMay 24, 2026

8m read

Altcoins

XCN

ENS

MKR

Onyxcoin Survived Collapse While Others Died

Onyxcoin (XCN) should not still exist. The protocol behind it was hacked twice through the same CompoundV2 precision bug, the second time for more than $3.8 million in September 2024, and dozens of similar forks simply died. Instead, XCN trades around $0.0049 with a $186 million market cap, 97% below its 2022 all-time high. What kept it alive was not a slick press release but a DAO that put the rebuild to an on-chain vote: new architecture, a fresh whitepaper, gas-free wallets, and the Goliath proof-of-stake Layer 1, whose mainnet went live on March 27, 2026. The catch is that shipping products and seeing them adopted are very different things. Infrastructure and price still do not match up, and a live governance proposal to end all future token unlocks could flip the supply story deflationary. For any Onyxcoin price prediction in 2026, the real question is whether the rebuilt community can generate organic demand, or whether XCN keeps trading on listing pumps and milestone hype.

Archie DuttonMay 23, 2026

9m read